Package 42799-963-02

{"route": ["ORAL"], "spl_id": "a7958920-40c7-4038-8524-3f830555d345", "openfda": {"unii": ["7D7RX5A8MO"], "rxcui": ["808744", "808748"], "spl_set_id": ["38431a76-6185-4c17-994f-8278b6cd7510"], "manufacturer_name": ["Edenbridge Pharmaceuticals LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (42799-963-01)", "package_ndc": "42799-963-01", "marketing_start_date": "20230315"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (42799-963-02)", "package_ndc": "42799-963-02", "marketing_start_date": "20230315"}], "brand_name": "venlafaxine hydrochloride, extended release", "product_id": "42799-963_a7958920-40c7-4038-8524-3f830555d345", "dosage_form": "TABLET", "pharm_class": ["Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "42799-963", "generic_name": "venlafaxine hydrochloride, extended release", "labeler_name": "Edenbridge Pharmaceuticals LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "venlafaxine hydrochloride, extended release", "active_ingredients": [{"name": "VENLAFAXINE HYDROCHLORIDE", "strength": "225 mg/1"}], "application_number": "ANDA209193", "marketing_category": "ANDA", "marketing_start_date": "20230315", "listing_expiration_date": "20271231"}